Abstract
Perioperative dry eye syndrome (DES) is a common ocular complication of long-term general anesthesia. Chronic DES can lead to permanent damage to the cornea and disturbance of visual function, up to total loss of vision. Here, a relationship between the duration of general anesthesia and the risk of chronic DES in patients was demonstrated. Using an experimental model of perioperative corneal abrasions in rabbits, it was found that introduction of animals to 3-h general anesthesia resulted in clinically significant chronic damage to the cornea in 50% of cases. The development of the complication was not associated with irreversible or long-term impairment of tear secretion, but it was accompanied by a decrease in tear film stability and growth of the total protein content as well as decrease in total antioxidant activity of the tear induced by low molecular weight antioxidants. In addition, anesthesia-induced changes in activity of tear antioxidant enzymes including superoxide dismutase and enzymes providing homeostasis of reduced glutathione (glutathione peroxidase, glutathione-S-transferase, glutathione reductase) were observed. All these alterations were protracted (up to 1-2 weeks) and therefore might account for transition of the perioperative DES into the chronic form. These findings can be useful in the development of novel approaches for the prevention and treatment of chronic forms of DES in the postanesthetic period.
Similar content being viewed by others
Abbreviations
- AOA:
-
antioxidant activity
- DES:
-
dry eye syndrome
- GPO:
-
glutathione peroxidase
- GR:
-
glutathione reductase
- GST:
-
glutathione-SH-transferase
- ROS:
-
reactive oxygen species
- SOD:
-
superoxide dismutase
References
Terry, H. R., Jr., Kearns, T. P., Love, J. G., and Orwoll, G. (1965) Untoward ophthalmic and neurologic events of anesthesia, Surg. Clin. North Am., 45, 927–938.
Snow, J. C., Kripke, B. J., Norton, M. L., Chandra, P., and Woodcome, H. A. (1975) Corneal injuries during general anesthesia, Anesth. Analg., 54, 465–467.
Batra, Y. K., and Bali, I. M. (1977) Corneal abrasions during general anesthesia, Anesth. Analg., 56, 363–365.
Cucchiara, R. F., and Black, S. (1988) Corneal abrasion during anesthesia and surgery, Anesthesiology, 69, 978–979.
Roth, S., Thisted, R. A., Erickson, J. P., Black, S., and Schreider, B. D. (1996) Eye injuries after nonocular surgery. A study of 60,965 anesthetics from 1988 to 1992, Anesthesiology, 85, 1020–1027.
White, E., and Crosse, M. M. (1998) The aetiology and prevention of peri-operative corneal abrasions, Anaesthesia, 53, 157–161.
Alves, M., Fonseca, E. C., Alves, M. F., Malki, L. T., Arruda, G. V., Reinach, P. S., and Rocha, E. M. (2013) Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies, Ocul. Surf., 11, 181–192.
Dogru, M., Nakamura, M., Shimazaki, J., and Tsubota, K. (2013) Changing trends in the treatment of dry-eye disease, Expert. Opin. Investig. Drugs, 22, 1581–1601.
Cross, D. A., and Krupin, T. (1977) Implications of the effects of general anesthesia on basal tear production, Anesth. Analg., 56, 35–37.
Hrazdirova, V., Navratilova, B., and Ventrubova, R. (1990) Use of contact lenses during general anesthesia, Cesk. Oftalmol., 46, 223–229.
Krupin, T., Cross, D. A., and Becker, B. (1977) Decreased basal tear production associated with general anesthesia, Arch. Ophthalmol., 95, 107–108.
Tikhomirova, N. K., Averina, O. A., Chemodanov, D. V., Ishutina, I. E., Sotnikova, L. F., Neverovsky, A. E., Zernii, E. Y., Philippov, P. P., and Senin, I. I. (2015) Development of dry eye syndrome under conditions of general anesthesia, Proc. Int. Sci. Pract. Conf. “Current problems and advances in medicine”, Vol. 2, pp. 60–62.
Gild, W. M., Posner, K. L., Caplan, R. A., and Cheney, F. W. (1992) Eye injuries associated with anesthesia. A closed claims analysis, Anesthesiology, 76, 204–208.
Wipperman, J. L., and Dorsch, J. N. (2013) Evaluation and management of corneal abrasions, Am. Fam. Physician, 87, 114–120.
Lemp, M. A. (1995) Report of the national eye institute/industry workshop on clinical trials in dry eyes, CLAO J., 21, 221–232.
Bhattacharya, D., Ning, Y., Zhao, F., Stevenson, W., Chen, R., Zhang, J., and Wang, M. (2015) Tear production after bilateral main lacrimal gland resection in rabbits, Invest. Ophthalmol. Vis. Sci., 56, 7774–7783.
Gautheron, P. D., Lotti, V. J., and Le Douarec, J. C. (1979) Tear film breakup time prolonged with unmedicated cellulose polymer inserts, Arch. Ophthalmol., 97, 1944–1947.
Gulidova, O. V., Liubitskii, O. B., Klebanov, G. I., and Chesnokova, N. B. (1999) Changes in the antioxidative activity of tears during experimental eye burns, Bull. Exp. Biol. Med., 128, 571–574.
Zernii, E. Y., Baksheeva, V. E., Iomdina, E. N., Averina, O. A., Permyakov, S. E., Philippov, P. P., Zamyatnin, A. A., and Senin, I. I. (2016) Rabbit models of ocular diseases: new relevance for classical approaches, CNS Neurol. Disord. Drug Targets, 15, 267–291.
Gogia, R., Richer, S. P., and Rose, R. C. (1998) Tear fluid content of electrochemically active components including water soluble antioxidants, Curr. Eye Res., 17, 257–263.
Choy, C. K., Cho, P., Chung, W. Y., and Benzie, I. F. (2001) Water-soluble antioxidants in human tears: effect of the collection method, Invest. Ophthalmol. Vis. Sci., 42, 3130–3134.
Aragona, P., Aguennouz, M., Rania, L., Postorino, E., Sommario, M. S., Roszkowska, A. M., De Pasquale, M. G., Pisani, A., and Puzzolo, D. (2015) Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease, Ophthalmology, 122, 62–71.
Runstrom, G., Mann, A., and Tighe, B. (2013) The fall and rise of tear albumin levels: a multifactorial phenomenon, Ocul. Surf., 11, 165–180.
Chen, Y., Mehta, G., and Vasiliou, V. (2009) Antioxidant defenses in the ocular surface, Ocul. Surf., 7, 176–185.
Behndig, A., Svensson, B., Marklund, S. L., and Karlsson, K. (1998) Superoxide dismutase isoenzymes in the human eye, Invest. Ophthalmol. Vis. Sci., 39, 471–475.
Gukasyan, H. J., Kim, K. J., Lee, V. H., and Kannan, R. (2007) Glutathione and its transporters in ocular surface defense, Ocul. Surf., 5, 269–279.
Hao, Y. H., Kuang, Z. H., Xu, Y., Walling, B. E., and Lau, G. W. (2013) Pyocyanin-induced mucin production is associated with redox modification of FOXA2, Respir. Res., 14, doi: 10.1186/1465-9921-14-82.
Grover, V. K., Kumar, K. V., Sharma, S., Sethi, N., and Grewal, S. P. (1998) Comparison of methods of eye protection under general anaesthesia, Can. J. Anaesth., 45, 575–577.
Schmidt, P., and Boggild-Madsen, N. B. (1981) Protection of the eyes with ophthalmic ointments during general anaesthesia, Acta Ophthalmol. (Copenh.), 59, 422–427.
Siffring, P. A., and Poulton, T. J. (1987) Prevention of ophthalmic complications during general anesthesia, Anesthesiology, 66, 569–570.
Ganidagli, S., Cengi, M., Becerik, C., Oguz, H., and Kilic, A. (2004) Eye protection during general anaesthesia: comparison of four different methods, Eur. J. Anaesthesiol., 21, 665–667.
Cejkova, J., and Cejka, C. (2015) The role of oxidative stress in corneal diseases and injuries, Histol. Histopathol., 30, 893–900.
Pinazo-Duran, M. D., Gallego-Pinazo, R., Garcia-Medina, J. J., Zanon-Moreno, V., Nucci, C., Dolz-Marco, R., Martinez-Castillo, S., Galbis-Estrada, C., Marco-Ramirez, C., Lopez-Galvez, M. I., Galarreta, D. J., and Diaz-Llopis, M. (2014) Oxidative stress and its downstream signaling in aging eyes, Clin. Interv. Aging, 9, 637–652.
Tsubota, K., Kawashima, M., Inaba, T., Dogru, M., Ogawa, Y., Nakamura, S., Shinmura, K., Higuchi, A., and Kawakita, T. (2010) The era of antiaging ophthalmology comes of age: antiaging approach for dry eye treatment, Ophthalmic Res., 44, 146–154.
Brzheskiy, V. V., Efimova, E. L., Vorontsova, T. N., Alekseev, V. N., Gusarevich, O. G., Shaidurova, K. N., Ryabtseva, A. A., Andryukhina, O. M., Kamenskikh, T. G., Sumarokova, E. S., Miljudin, E. S., Egorov, E. A., Lebedev, O. I., Surov, A. V., Korol, A. R., Nasinnyk, I. O., Bezditko, P. A., Muzhychuk, O. P., Vygodin, V. A., Yani, E. V., Savchenko, A. Y., Karger, E. M., Fedorkin, O. N., Mironov, A. N., Ostapenko, V., Popeko, N. A., Skulachev, V. P., and Skulachev, M. V. (2015) Results of a multicenter, randomized, double-masked, placebo-controlled clinical study of the efficacy and safety of visomitin eye drops in patients with dry eye syndrome, Adv. Ther., 32, 1263–1279.
Petrov, A., Perekhvatova, N., Skulachev, M., Stein, L., and Ousler, G. (2016) SkQ1 ophthalmic solution for dry eye treatment: results of a phase 2 safety and efficacy clinical study in the environment and during challenge in the controlled adverse environment model, Adv. Ther., 33, 96–115.
Yani, E. V., Katargina, L. A., Chesnokova, N. V., Beznos, O. V., Savchenko, A. Yu., Vigodin, V. A., Gudkova, E. Yu., Zamyatnin, A. A., Jr., and Skulachev, M. V. (2012) The first experience of using vizomitin drug in the treatment of “dry eye”, Prakt. Med., 1, 134–137.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM16-243, October 24, 2016.
Rights and permissions
About this article
Cite this article
Zernii, E.Y., Golovastova, M.O., Baksheeva, V.E. et al. Alterations in tear biochemistry associated with postanesthetic chronic dry eye syndrome. Biochemistry Moscow 81, 1549–1557 (2016). https://doi.org/10.1134/S0006297916120166
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297916120166